HOME >> BIOLOGY >> NEWS
A novel molecular dictator 'with a conscience' discovered

University of New South Wales (UNSW) researchers have uncovered an important naturally occurring mechanism in the body where "bad" cells that cause blockages in our blood vessels are kept under strict growth control, while "good" cells that keep our blood vessels free of clots and growths are left unaffected.

The discovery is expected to benefit those who will need heart coronary bypass surgery, an angioplasty - the mechanical widening of a narrowed or totally blocked blood vessel - or will undergo haemodialysis.

Professor Levon Khachigian, from UNSWs Centre for Vascular Research, who previously pioneered "molecular assassin" drug technology, describes this novel mechanism he discovered as a molecular dictatorship with a conscience.

"The dictator is a specific gene suppressor called YY1, which has the therapeutically appealing capacity to differentiate between certain cell types when it goes about its activity," says Professor Khachigian.

This key finding has just been published in the world's premier cardiovascular research journal, Circulation Research.

Professor Khachigian's research provides new hope in tackling the global problems of coronary bypass graft failure, and restenosis - the closing or narrowing of an artery that was previously opened by a procedure such as angioplasty.

"While the most effective way to head off restenosis is a drug-coated stent, the drugs that sit on these stents inhibit the growth of good cells as well as the bad.

If you had to have catheter intervention to re-open an occluded artery, for sustained symptom-free benefit you would be hoping for suppressed smooth muscle cell growth, without affecting endothelial cell growth, says Professor Khachigian.

And thats exactly what happens when we simply top up blood vessels with the bodys natural reserves of YY1."


'"/>

Contact: Susi Hamilton
susi.hamilton@unsw.edu.au
61-422-934-024
University of New South Wales
22-Jul-2007


Page: 1

Related biology news :

1. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
2. UB scientist discovers novel iron-copper alliance
3. Researchers pit novel version of common virus against cancer
4. UCLA researchers discover novel pathway that may promote immune system balance
5. pHLIP, a novel technology to locate and treat tumors
6. Bioluminescence at the service of a novel cerebral imaging technique
7. Application of Genomatix in silico methods reveals novel cancer associated genes
8. Two studies: Speeding development of novel tracer for prostate cancer
9. Erythrocyte G protein as a novel target for malarial chemotherapy
10. U of MN researchers find novel genes critical in organ development
11. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... (PRWEB) , ... February 11, 2020 , ... ... firm, is pleased to announce it achieved its ISO 9001:2015 registration by certification ... preparation for the audits, she reviewed and revised all existing Standard Operating Procedures ...
(Date:2/11/2020)... ... February 11, 2020 , ... The LaunchPort™ announced ... accelerator in Port Covington, Baltimore. The newly formed company is developing a novel ... manage increased demand for home dialysis treatments. The start-up company will be moving ...
(Date:2/7/2020)... ... February 07, 2020 , ... dicentra , a ... product, nutraceutical and dietary supplement industries, announces 2020 membership with the International Probiotics ... and research pertaining to probiotics. We are thrilled to join our IPA member ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... , ... February 20, 2020 , ... ... supply chain transparency and reassuring consumers that what’s listed on an ingredient panel ... ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which is ...
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, ... the strain level, recently unveiled a novel DNA isolation product. , Shoreline Rapid ... of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB ...
(Date:2/13/2020)... ... February 12, 2020 , ... Arriello , a ... adopting Veeva Vault Safety™ as part of the company’s continued growth ... data, processing of safety information such as SUSARs and ICSRS, aggregate report production, ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is now registering ... Las Vegas. The course is hands on involving real patients and stem cell biologics, ... the Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love ...
Breaking Biology Technology:
Cached News: